"We need more peer to peer sharing through conferences and grand rounds. We need to look at research into increasing efficacy in under-served populations, different head shapes, and anthracyclines." Richard Paxman sits down with oncology thought leaders and renowned clinical trial experts, to review scalp cooling trial data and results from the past decade, and consider what needs to be looked at next to improve efficacy within under-served populations.  The group argue that scalp cooling tolerability and efficacy is well established and now is the time to look at more specific determinan ..read more

"Always offer, it is up to patient to figure out whether or not they can afford something, and not up to us to assume whether they can afford something"    Diversity and equity are currently high on the healthcare agenda - however there are still noticeable inconsistencies when it comes to side effect management in cancer care. Maimah Karmo, Founder of Tigerlily Foundation, sits down with oncologists and patient advocates to discuss why having appropriate individualized care is incredibly important for minority populations, with many chemotherapy side effects centred on skin toxiciti ..read more

"We talk to our patients a lot about being self-empowered – this is your opportunity to really self-manage this and take some responsibility in terms of the outcome." Dr Lindsay Peterson sits down with a multidisciplinary group of physicians, to discuss the wider picture surrounding protocols within chemotherapy side-effect management. They consider the often challenging integration of practices such as scalp cooling, and discuss their tried and tested approaches, detailed workflows, and the importance of interdisciplinary buy-in within their medical institutions, which has had a real impact o ..read more

For Season 2 of the podcast, you can hear some of the best bits from our Summit Series. Launches 29th March 2023. For more visit https://scalpcoolingsummit.com/  ..read more

In this bonus episode, Corina van den Hurk of the Netherlands Comprehensive Cancer Organisation discusses the expansion of the Dutch Scalp Cooling Registry to include international data, following the success of the database of over 7,000 Dutch patients scalp cooling results, which has provided a vital insight into scalp cooling efficacy. Maryam Lustberg, Chief of Breast at Yale Cancer Centre, also expresses her support for the registry, as it continues to drive the movement towards precision symptom management within cancer care. As well as providing an insight on how Corina and her team are ..read more

In this episode, Rich is joined by Dr Raghav Sundar and Dr Aishwarya Bandla from the National University Cancer Institute in Singapore. They discuss their research surrounding chemotherapy-induced peripheral neuropathy, which has been paramount in making further steps towards managing this often life-changing side effect. They discuss why CIPN was often viewed by clinicians as the price to pay for curing cancer when there was no effective intervention on the horizon, and that patients are often unaware of the side effect until they begin to suffer from it. Looking to the future, Raghav and Ais ..read more

In this episode, Rich chats with Dr Conleth Murphy, a consultant medical oncologist and Sue Glavin, Nurse Manager who are both leading the way in scalp cooling treatment at Bon Secours Hospital in Cork, Ireland.  They discuss how patient advocacy played a huge part in integrating scalp cooling into their side effect management practice. As well as the psychosocial impact that scalp cooling can have on patients. Both go into depth about how providing care can limit the impact of cancer on a patient both during and after their treatment.  ..read more

In this episode, Rich firstly chats with Dr Jyoti Bajpai, an oncologist in Mumbai who prioritises providing precision symptom care for her patients, despite the 100+ patients she sees daily.  They discuss Bajpai’s randomised controlled trial on scalp cooling, her discoveries on regrowth as a secondary endpoint, and the importance of treatment sequencing to reflect each individual patient’s definition of success. Rich then speaks to Professor Masakazu Toi, a breast oncologist from the Kyoto University in Japan. We discuss his involvement in the HOPE Study – a multicenter controlled clinica ..read more

In our first episode, Richard meets with Dr. Maryam Lustberg, Chief of Breast Medical Oncology at Yale Cancer Centre, and Dr. Corina van den Hurk of the Netherlands Comprehensive Cancer organisation. Maryam and Corina are both paving the way in side effect management for chemotherapy patients across the globe. We discuss their current research initiatives, their own personal connections with scalp cooling, and the need for better symptom management care, to improve patient's quality of life as well as their treatment.  ..read more

In this podcast, CEO of Paxman Scalp Cooling Richard Paxman will be speaking to renowned oncologists, clinical researchers and medical thought leaders, to discuss how chemotherapy side effects impact on a patients physical and mental wellbeing - and ask, how is oncology care tackling these side effects?   He’ll be discussing the development and practice of side effect management across the globe, and challenging healthcare preconceptions about what patients want, in addition to what they medically need.   By investigating the true meaning of patient-centric-care and the barriers whic ..read more